TROMBETTA, Maddalena
 Distribuzione geografica
Continente #
NA - Nord America 2.897
EU - Europa 2.862
AS - Asia 963
AF - Africa 9
OC - Oceania 8
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.747
Nazione #
US - Stati Uniti d'America 2.875
GB - Regno Unito 1.411
CN - Cina 634
SE - Svezia 274
IT - Italia 229
FR - Francia 196
IE - Irlanda 193
FI - Finlandia 158
RU - Federazione Russa 148
DE - Germania 135
SG - Singapore 108
KR - Corea 56
VN - Vietnam 49
UA - Ucraina 43
IN - India 24
PK - Pakistan 20
JP - Giappone 18
BE - Belgio 17
CA - Canada 16
HK - Hong Kong 15
GR - Grecia 12
TR - Turchia 11
NL - Olanda 10
AT - Austria 7
AU - Australia 6
GH - Ghana 6
RO - Romania 6
SA - Arabia Saudita 5
BD - Bangladesh 4
IR - Iran 4
CZ - Repubblica Ceca 3
LV - Lettonia 3
AL - Albania 2
AR - Argentina 2
BR - Brasile 2
CR - Costa Rica 2
DK - Danimarca 2
EG - Egitto 2
HU - Ungheria 2
ID - Indonesia 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PL - Polonia 2
TH - Thailandia 2
AZ - Azerbaigian 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
MX - Messico 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 6.747
Città #
Southend 1.336
Chandler 543
Ashburn 445
Jacksonville 321
Woodbridge 234
Ann Arbor 208
Dublin 193
Beijing 164
Houston 148
New York 117
Verona 95
Wilmington 84
Lawrence 78
Princeton 78
Jinan 66
Singapore 62
Helsinki 55
Nanjing 53
Seoul 45
Shenyang 45
Boardman 37
Dong Ket 36
Sindelfingen 29
Hebei 26
Redmond 26
Zhengzhou 23
Tianjin 21
Lancaster 20
Nanchang 20
Los Angeles 18
Brussels 17
Mianwali 17
Milan 17
Hangzhou 16
Taiyuan 16
Dearborn 15
Kent 15
Bologna 14
Haikou 14
Hong Kong 13
Redwood City 13
Washington 13
Changsha 12
Tokyo 12
Hyderabad 11
Taizhou 11
Dallas 10
Dongguan 10
Jiaxing 10
Ningbo 9
Seattle 9
Cagliari 8
Nikaia 8
San Francisco 8
Bolzano 7
Guangzhou 7
Toronto 7
Vienna 7
Accra 6
Fuzhou 6
Malda 6
Norwalk 6
Auburn Hills 5
Chicago 5
Bucharest 4
Dhaka 4
Düsseldorf 4
Fairfield 4
Lanzhou 4
Santa Clara 4
Shenzhen 4
Sydney 4
Tehran 4
Yongin-si 4
Belluno 3
Brendola 3
Catanzaro 3
Delhi 3
Groningen 3
Guiyang 3
Kemerovo 3
Kharkov 3
Kitchener 3
Kochi 3
London 3
Phoenix 3
Riyadh 3
Trento 3
Vicopisano 3
Almere Stad 2
Amsterdam 2
Athens 2
Atlanta 2
Auckland 2
Bari 2
Berlin 2
Brighton 2
Budapest 2
Cairo 2
Chengdu 2
Totale 5.093
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 618
Common Variants Associated to Type 2 Diabetes in the Italian Population 368
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Chronic Kidney Disease in Patients With Type 1 Diabetes. 166
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 126
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 125
Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance 121
Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: results from the RAED2 randomized trial 108
Potential role of MTNR1B locus in regulating beta cell function and glucose levels in patients with newly diagnosed type 2 diabetes 105
Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes. 105
Variants and haplotypes of TCF7L2 are associated with beta cell function in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).1. 100
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4. 99
Diabetic foot complicated by vertebral osteomyelitis and epidural abscess 98
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 98
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 97
Abstracts of 51st EASD Annual Meeting 94
“Genetic Load” of diabetes risk alleles affects beta-cell function in patients with newly diagnosed type 2 diabetes 91
Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 91
Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study). 90
Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5 89
Relation of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes. 88
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 88
Confronto degli effetti metabolici dell'esercizio aerobico e dell'esercizio di forza nel diabete tipo 2 88
A parsimonious model of a mixed-meal test in patients with type 1 diabetes in insulin pump therapy 87
Variants in CACNA1E affect beta cell function and glucose homeostasis in newly diagnosed type 2 diabetes patients 86
Increased aortic stiffness index in patients with type 1 diabetes without cardiovascular disease compared to controls 86
Body mass index is a potential modifier of the influence on beta cell function exerted by SLC30A8 and KCNJ11 diabetes risk variants in patients with newly diagnosed type 2 diabetes 84
Beta-cell function across the spectrum of glucose tolerance in obese youth. 82
Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease. 82
Impaired Aortic Valve Growth in Type 1 Diabetes Mellitus 81
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 80
Association between subclinical left ventricular systolic dysfunction and glycemic control in asymptomatic type 2 diabetic patients with preserved left ventricular function 80
In patients with newly-diagnosed type 2 diabetes beta cell function is an independent predictor of glucose control evolution over 18 months 79
Relationship between soluble CD40 ligand and gamma-glutamyltransferase concentrations in non-drinking, young type 1 diabetic individuals 78
Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. 78
A low "genetic load" of risk variants for type 2 diabetes is associated to better beta cell function in patients with newly diagnosed type 2 diabetes 78
Assessement of 1th and snd phase of insulin secretion during OGTT and IVGTT 76
Evaluating endothelial function of the common carotid artery: An in vivo human model. 76
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 75
Confronto delle variazioni acute della glicemia indotte dall'esercizio fisico aerobico o di forza muscolare: studio mediante holter glicemico 75
Heritability of model-derived parameters of beta cell secretion during intravenous and oral glucose tolerance tests: a study of twins. 74
Insulin sensitivity and beta-cell function: Relationships to glycemic control in newly diagnosed Type 2 diabetic patients 74
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 72
Aerobic and resistence exercise have different short-term effect on glucose levels in type 2 diabetes subject 71
Quantitation of the roles played by the main determinants of meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy 71
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease 71
Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function 70
Differences in the acute effects of aerobic and resistance exercise in subjects with type 2 diabetes: Results from the RAED2 randomized trial - Note in: Riddell et al., Physical activity and exercise 70
Cutaneous squamous carcinoma in a patient with diabetic foot: an unusual evolution of a frequent complication 70
Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. 69
Pathogenetic Mechanisms and Cardiovascular Risk: Differences between HbA1c and oral glucose tolerance test for the diagnosis of glucose tolerance. 69
PPARgamma Pro12Ala and ADAMTS9 rs4607103 are determinants of insulin sensitivity in both non-diabetic and type 2 diabetic Italian subjects 69
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 69
Continuous subcutaneous insulin infusion in Italy: third national survey. 67
Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes 67
Uric acid is a biomarker of beta cell function in patients with newly diagnosed type 2 diabetes 65
Defects in the dynamic control of beta cell function and in glucose effectiveness underly the initial decline in intravenous glucose tolerance of obese European children 64
Effects of angiotensin II receptor inhibition on insulin-induced endothelial dysfunction in humans. 64
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9 63
Metabolic control analysis (MCA) of intravenous glucose tolerance in healthy humans. 61
Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. 61
Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents. 60
Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy 60
Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11) 60
Estimated peak systolic pulmonary artery pressure in young non-complicated patients with type 1 diabetes 58
Growing up with type 1 diabetes mellitus: Data from the Verona Diabetes Transition Project 58
Variability of body weight, pulse pressure and glycemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study. 57
Review article: type 2 diabetes and chronic liver disease in the Verona Diabetes Study 55
Accuracy of CGM Systems During Continuous and Interval Exercise in Adults with Type 1 Diabetes 54
Methods to assess in vivo insulin sensitivity and insulin secretion 50
Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients 49
Depressive symptoms and glycaemic control in adults with type 1 diabetes: an exploratory study on the role of family functioning 49
Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 13 48
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12 46
Continuous intraperitoneal insulin infusion: an alternative route for insulin delivery in type 1 diabetes 43
Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes 41
Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study. 38
Loss of ZnT8 function protects against diabetes by enhanced insulin secretion 33
SARS-CoV-2 and COVID-19 in diabetes mellitus. Population-based study on ascertained infections, hospital admissions and mortality in an Italian region with ∼5 million inhabitants and ∼250,000 diabetic people 31
Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity 29
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 29
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 25
Glucose tolerance stages in Cystic Fibrosis are idenfied by a unique pattern of defects of Beta-cell function 23
G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children 21
A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes 20
Markers of subclinical vascular damage in young adults with type 1 diabetes mellitus: the role of central blood pressure 20
Correction to: Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT‑IPA questionnaire) 18
Lower heart rate variability, an index of worse autonomic function, is associated with worse beta cell response to a glycemic load in vivo—The Maastricht Study 11
Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14 10
Assessing attitudes towards insulin pump therapy in adults with type 1 diabetes: Italian validation of the Insulin Pump Attitudes Questionnaire (IT-IPA questionnaire) 10
Totale 6.953
Categoria #
all - tutte 22.416
article - articoli 15.662
book - libri 0
conference - conferenze 6.563
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 191
Totale 44.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020762 0 0 30 72 87 105 98 51 44 102 71 102
2020/2021761 45 109 46 72 95 80 25 44 59 39 65 82
2021/2022664 82 154 19 55 23 36 13 32 24 18 54 154
2022/20231.427 101 196 120 255 130 323 17 80 139 14 34 18
2023/20241.308 36 61 74 102 100 217 32 308 10 130 164 74
2024/2025230 96 134 0 0 0 0 0 0 0 0 0 0
Totale 6.953